Parents in Kerala concerned about changes in 'Mittayi' scheme for children with Type 1 diabetes, facing insulin issues.

On July 15, 2025, Biocon Biologics, a fully integrated global biosimilars company and a subsidiary of Biocon Ltd., announced that the FDA has ...